Professor David Webb
Christison Chair of Therapeutics and Clinical Pharmacology, University of Edinburgh; WCP2022 President
Country: United Kingdom
Specialty/Research area: Cardiovascular/Clinical Pharmacology
Online profile: https://orcid.org/0000-0003-0755-1756
David is Christison Professor of Therapeutics & Clinical Pharmacology at the University of Edinburgh, a Fellow of the Royal Society of Edinburgh and Academy of Medical Sciences (AMS), and Honorary Fellow of BPS and Faculty of Pharmaceutical Medicine. Through a Wellcome Trust Cardiovascular Award, he created the University/BHF Centre for Cardiovascular Science, and contributed to establishing the Queen’s Medical Research Institute, where he is a Principle Investigator and heads the Hypertension/Renal Section. He leads Edinburgh’s ESH-accredited Hypertension Excellence Centre, and his research focuses on understanding arterial structure and function and improving management of hypertension and renal disease, with translational work on inhibitors of ACE, ET-1, PDE5 and renin. He has received the SKB Silver and Lilly Gold Medals from BPS for research in and contributions to clinical pharmacology respectively. He has an h-Index >100.
David is Executive Member of IUPHAR and its Clinical Division, Deputy Chair of MHRA (the UK’s medicines regulator), and chairs NIBSC’s Scientific Advisory Committee and BPS/Medical Schools Council Prescribing Safety Assessment (PSA) Executive. He is Past-President of BPS, and of the Scottish Society of Physicians, and Honorary President of EACPT (Edinburgh 2009). He has previously chaired the Scottish Medicines Consortium (Scotland’s equivalent of NICE).